paclitaxel
common
chemotherapi
drug
associ
develop
chronic
paclitaxelinduc
peripher
neuropathi
pipn
pipn
associ
neuroinflammatori
mechan
preclin
studi
evalu
differenti
gene
express
dge
peripher
blood
breast
cancer
survivor
without
pipn
neuroinflammatori
ni
relat
signal
pathway
wholetranscriptom
profil
experi
pathway
impact
analysi
identifi
perturb
ni
relat
pathway
express
profil
analysi
found
experi
similar
wholetranscriptom
profil
dge
relat
neuroinflamm
pipn
find
suggest
perturb
pathway
associ
neuroinflamm
found
cancer
survivor
pipn
paclitaxel
extrem
effect
chemotherapeut
agent
treatment
breast
ovarian
lung
cancer
kudlowitz
muggia
howev
paclitaxelinduc
peripher
neuropathi
pipn
major
doselimit
toxic
occur
patient
receiv
drug
jone
et
al
sarosi
et
al
paclitaxel
antitubulin
drug
caus
microtubul
stabil
peripher
nervou
system
administr
paclitaxel
result
distal
axon
degener
secondari
demyelin
nerv
fiber
loss
gornstein
schwarz
sahenk
et
al
grow
bodi
evid
implic
neuroinflamm
develop
pipn
makker
et
al
wang
et
al
chemotherapi
ctx
drug
cross
bloodbrainbarri
readili
penetr
bloodnervebarri
bind
accumul
dorsal
root
ganglia
drg
peripher
axon
gornstein
schwarz
park
et
al
addit
direct
neurotox
effect
ctx
induc
neuroinflamm
activ
immun
immunelik
glial
cell
fact
grow
bodi
preclin
evid
suggest
immun
cell
eg
macrophag
lymphocyt
glial
cell
eg
schwann
cell
peripher
nervou
system
pn
astrocyt
microglia
central
nervou
system
cn
play
import
role
induct
mainten
neuropath
pain
krame
zhang
et
al
activ
immun
system
result
releas
inflammatori
mediat
within
drg
dorsal
horn
krame
enhanc
neuron
excit
result
pain
hypersensit
peripher
neuron
makker
et
al
patient
develop
neurotox
suggest
molecular
factor
may
play
role
develop
pipn
fact
recent
report
use
rnaseq
data
breast
cancer
patient
n
n
develop
pipn
kober
et
al
identifi
nine
perturb
pathway
associ
variou
aspect
mitochondri
dysfunct
includ
oxid
stress
iron
homeostasi
mitochondri
fission
apoptosi
autophagi
paper
extend
find
describ
differenti
perturb
pathway
well
whole
transcriptom
profil
differenti
gene
express
dge
associ
neuroinflamm
sampl
breast
cancer
survivor
n
without
n
chronic
pipn
studi
use
two
differ
approach
evalu
whole
transcriptom
data
pattern
dge
biolog
pathway
associ
neuroinflamm
pipn
fig
first
approach
util
pathway
impact
analysi
pia
welldefin
signal
pathway
evalu
perturb
use
signific
magnitud
genegen
interact
dge
test
second
approach
ie
express
profil
analysi
epa
compar
whole
transcriptom
pattern
dge
breast
cancer
survivor
without
cipn
databas
publicli
avail
well
annot
gene
express
experi
identifi
system
studi
similar
pattern
analysi
use
demograph
clinic
gene
express
data
previou
studi
kober
et
al
method
gene
express
analysi
describ
detail
elsewher
kober
et
al
gene
express
total
rna
isol
peripher
blood
assay
use
rnaseq
gene
express
summar
count
per
gene
use
input
pia
epa
analys
differenti
gene
express
quantifi
use
gener
linear
model
kober
et
al
dge
analys
adjust
demograph
ie
age
employ
statu
clinic
ie
alcohol
use
disord
identif
test
audit
bohn
et
al
score
bodi
mass
index
bmi
karnofski
perform
score
kp
karnofski
karnofski
et
al
schnadig
et
al
score
characterist
differ
pipn
group
well
technic
overview
analyt
approach
use
evalu
neuroinflamm
relat
pathway
gene
express
experi
associ
paclitaxelinduc
peripher
neuropathi
pipn
differenti
gene
express
dge
peripher
blood
found
breast
cancer
survivor
p
without
n
paclitaxelinduc
peripher
neuropathi
evalu
perturb
neuroinflamm
relat
signal
pathway
use
pathway
impact
analysi
experi
gene
express
omnibu
geo
similar
wholetranscriptom
profil
differenti
gene
express
relat
neuroinflamm
pipn
use
express
profil
analysi
taken
togeth
result
suggest
perturb
proand
antiinflammatori
pathway
associ
neuroinflamm
found
cancer
survivor
pipn
variabl
eg
potenti
batch
effect
dge
result
summar
log
fold
chang
pvalu
gene
pia
use
evalu
perturb
welldefin
signal
pathway
pia
includ
potenti
import
biolog
factor
eg
genegen
interact
flow
signal
pathway
pathway
topolog
magnitud
ie
log
foldchang
pvalu
differenti
express
de
analysi
review
mitrea
et
al
pia
includ
result
de
analysi
gene
ie
cutoff
free
determin
probabl
pathway
perturb
ppert
use
pathway
express
draghici
et
al
total
signal
pathway
defin
use
kyoto
encyclopedia
gene
genom
kegg
databas
aokikinoshita
kanehisa
sequenc
loci
data
annot
entrez
gene
id
gene
symbol
annot
use
hugo
gene
nomenclatur
committe
resourc
databas
gray
et
al
assess
signific
pia
use
strict
fals
discoveri
rate
fdr
benjaminihochberg
bh
procedur
benjamini
hochberg
hochberg
benjamini
final
evalu
result
specif
pathway
relat
neuroinflamm
evalu
whole
transcriptom
pattern
dge
relationship
neuroinflamm
pipn
compar
find
independ
well
annot
publicli
avail
data
set
gene
express
util
profilechas
engreitz
et
al
develop
transcriptom
wide
profil
dge
pattern
pipn
pipn
group
compar
profil
ncbi
gene
express
omnibu
geo
curat
geo
dataset
gd
avail
gd
includ
gene
express
data
wide
varieti
tissu
speci
studi
design
studi
annot
number
characterist
term
factor
eg
sampl
id
age
cell
line
treatment
group
profilechas
gener
refer
profil
pairwis
comparison
factor
defin
gd
compar
queri
dataset
identifi
similar
refer
profil
way
profilechas
identifi
experi
similar
biolog
condit
queri
experi
perform
evalu
avail
gd
annot
factor
limit
bia
priori
filter
gene
level
summari
rna
abund
annot
entrez
id
estim
log
transform
read
per
mean
thousand
ie
log
assess
signific
epa
use
strict
fdr
bh
procedur
benjamini
hochberg
hochberg
benjamini
use
previou
method
kober
et
al
evalu
signific
find
interpret
base
experiment
design
refer
profil
previous
report
kober
et
al
survivor
pipn
significantli
older
p
like
unemploy
p
term
clinic
characterist
survivor
pipn
lower
audit
score
p
higher
bodi
mass
index
bmi
p
lower
kp
score
p
note
group
differ
found
total
cumul
dose
paclitaxel
receiv
percentag
patient
dose
reduct
delay
due
pipn
see
supplementari
tabl
supplementari
tabl
summar
selfreport
pain
characterist
survivor
pipn
worst
pain
sever
report
ten
durat
pipn
year
survivor
pipn
higher
number
lower
extrem
site
loss
light
touch
cold
pain
sensat
p
vibrat
threshold
significantli
higher
pipn
group
p
supplementari
tabl
survivor
pipn
like
report
troubl
balanc
p
well
higher
sever
distress
p
score
associ
balanc
problem
addit
survivor
report
wors
time
get
go
p
wors
fullerton
advanc
balanc
p
score
supplementari
tabl
success
annot
entrez
id
perform
uniqu
gene
fold
chang
pvalu
de
analysi
gene
includ
pathway
perturb
analysi
kegg
signal
pathway
pia
identifi
kegg
signal
pathway
significantli
perturb
pipn
group
correct
multipl
hypothesi
test
conserv
fdr
adjust
perturb
pvalu
kegg
signal
pathway
relat
neuroinflamm
tabl
whole
transcriptom
profil
evalu
similar
dge
sampl
survivor
without
pipn
profil
across
uniqu
gd
identifi
use
epa
supplementari
file
evalu
studi
design
profil
profil
uniqu
gd
publish
studi
identifi
associ
neuroinflamm
pipn
find
organ
six
categori
base
similar
biolog
characterist
tabl
abbrevi
ampk
adenosin
monophosphateactiv
protein
kinas
gaba
gamma
amino
butyr
acid
il
interleukin
kegg
kyoto
encyclopedia
gene
genom
nf
nuclear
factor
nod
nucleotidebind
oligomer
domain
tgf
transform
growth
factor
ppert
perturb
pvalu
adjust
use
benjaminihochberg
method
studi
first
provid
molecular
evid
number
neuroinflammatori
mechan
identifi
preclin
model
neuropath
pain
andor
pipn
flatter
et
al
et
al
perturb
cancer
survivor
pipn
note
review
role
cytokin
chemotherapyinduc
peripher
neuropathi
cipn
wang
et
al
proinflammatori
cytokin
chemokin
play
critic
role
develop
mainten
pain
peripher
neuropathi
consist
find
differenti
perturb
cytokinecytokin
receptor
interact
pathway
sever
line
preclin
evid
suggest
administr
paclitaxel
associ
activ
immun
immunelik
cell
pn
cn
exampl
follow
administr
intraven
paclitaxel
rat
number
activ
macrophag
drg
peripher
nerv
schwann
cell
increas
associ
allodynia
hyperalgesia
peter
et
al
macrophag
infiltr
result
product
releas
number
cytokin
eg
tumor
necrosi
factor
alpha
interleukin
chemokin
addit
schwann
cell
releas
prostaglandin
adenosin
triphosph
atp
ozturk
et
al
molecul
contribut
neuroinflamm
sommer
kress
tofari
et
al
addit
evid
preclin
model
peripher
neuropathi
support
find
perturb
nuclear
factor
nf
signal
pathway
exampl
build
observ
immunoreact
neuron
increas
ipsilater
side
partial
sciatic
nerv
injuri
bisbi
effect
pipn
evalu
rodent
model
kamei
et
al
studi
paclitaxel
increas
protein
level
spinal
phosphoryl
inhibitor
attenu
mechan
hyperalgesia
author
conclud
activ
mediat
paclitaxelinduc
hyperalgesia
anoth
preclin
studi
gui
et
al
intraperiton
administr
paclitaxel
induc
activ
upregul
astrocyt
activ
spinal
cord
anoth
perturb
pathway
studi
signal
pathway
famili
subset
cytokin
play
crucial
role
acut
chronic
inflammatori
respons
isailov
et
al
produc
cell
appear
play
role
inflammatori
lubbert
neuropath
day
et
al
kim
moalemtaylor
pain
recent
preclin
studi
express
spinal
cord
evalu
follow
spinal
nerv
ligat
mainten
phase
neuropath
pain
mrna
express
level
significantli
increas
dorsal
horn
spinal
cord
anim
nerv
injuri
author
conclud
may
contribut
neuropath
pain
promot
prolifer
astrocyt
secret
proinflammatori
cytokin
studi
found
role
cipn
astrocyt
appear
play
role
c
miaskowski
et
al
journal
neuroimmunolog
develop
chronic
pain
condit
robinson
dougherti
robinson
et
al
term
perturb
adipocytokin
signal
pathway
leptin
import
regul
energi
intak
metabol
rate
addit
leptin
influenc
normal
function
immun
system
stimul
cytokin
product
chemotaxi
addit
leptin
express
regul
cytokin
carniglia
et
al
studi
found
associ
leptin
cipn
rat
model
chronic
constrict
injuri
administr
leptin
antagonist
prevent
develop
injuryinduc
mechan
allodynia
thermal
hyperalgesia
lim
et
al
mous
model
partial
sciatic
nerv
ligat
maeda
et
al
leptin
product
induc
adipocyt
present
epineurium
injur
nerv
leptin
necessari
tactil
allodynia
associ
ligat
addit
leptin
enhanc
product
cyclooxygenas
cox
induc
nitric
oxid
synthas
ino
matrix
macrophag
suggest
adipokin
activ
macrophag
contribut
develop
neuropath
pain
howev
anoth
preclin
studi
leptin
exhibit
protect
effect
model
sciatic
nerv
injuri
fernandezmarto
et
al
variou
member
nucleotidebind
oligomer
domain
nod
like
receptor
signal
pathway
play
pivot
role
recognit
intracellular
ligand
particular
interest
grow
bodi
evid
suggest
one
member
pathway
ie
nodlik
receptor
protein
involv
variou
type
neuropath
pain
khan
et
al
li
et
al
pan
et
al
pu
et
al
tonkin
et
al
xu
et
al
note
recent
preclin
studi
pipn
rat
jia
et
al
paclitaxel
increas
express
activ
fragment
suggest
activ
inflammasom
express
locat
macrophag
infiltr
drg
sciatic
nerv
author
conclud
find
suggest
administr
paclitaxel
induc
mitochondri
damag
reactiv
oxygen
speci
product
result
activ
inflammasom
peripher
nerv
contribut
pipn
jia
et
al
preclin
studi
identifi
implic
transform
growth
factor
tgf
signal
pathway
develop
pipn
pathway
includ
number
structur
relat
cytokin
wide
spectrum
cellular
function
within
nervou
system
control
prolifer
neuron
regul
neuron
surviv
krieglstein
et
al
astroglia
exert
antiinflammatori
immunosuppress
effect
bottner
et
al
preclin
studi
prevent
develop
neuropath
pain
associ
traumat
nerv
injuri
revers
previous
establish
neuropath
pain
chen
et
al
chen
et
al
echeverri
et
al
gamma
amino
butyr
acid
gaba
abund
inhibitori
neurotransmitt
within
cn
variou
model
neuropath
pain
decreas
gaba
receptormedi
inhibitori
synapt
transmiss
dorsal
horn
neuron
occur
follow
nerv
injuri
gwak
hulsebosch
yin
et
al
addit
mous
model
pipn
braz
et
al
intraspin
transplant
cortic
precursor
gabaerg
interneuron
embryon
medial
ganglion
emin
revers
mechan
allodynia
heat
hyperalgesia
associ
administr
paclitaxel
note
recent
review
asiedu
et
al
adenosin
monophosphateactiv
protein
kinas
ampk
signal
pathway
novel
target
allevi
neuropath
pain
ampk
activ
inhibit
signal
pathway
known
promot
chang
peripher
nociceptor
result
chronic
pain
studi
evalu
role
ampk
cipn
maoy
et
al
coadministr
platinum
metformin
drug
activ
ampk
prevent
increas
latenc
associ
detect
adhes
patch
well
decreas
densiti
intraderm
nerv
fiber
follow
administr
ctx
mous
model
use
epa
identifi
similar
profil
experiment
system
inflammatori
respons
exerciseinduc
effect
preclin
model
pain
see
tabl
term
inflammatori
respons
similar
profil
dge
found
survivor
without
pipn
patient
sar
reghunathan
et
al
ockenhous
et
al
malaria
boldt
et
al
ockenhous
et
al
compar
healthi
presymptomat
individu
note
neuroinflamm
thought
play
major
role
develop
mainten
pipn
makker
duffi
wang
et
al
similar
chronic
pipn
profil
pathogenmedi
inflammatori
profil
suggest
system
inflammatori
process
may
play
role
develop
mainten
pipn
term
find
relat
exercisemedi
effect
limit
evid
exist
exercis
benefit
patient
variou
type
neuropath
pain
dobson
et
al
includ
cipn
kleckner
et
al
studi
compar
survivor
without
pipn
survivor
pipn
report
exercis
regular
basi
p
epa
dge
profil
blood
healthi
volunt
taken
increas
level
exercis
buttner
et
al
connolli
et
al
similar
profil
survivor
without
pipn
addit
research
warrant
associ
two
previou
analys
cipn
miaskowski
et
al
pipn
kober
et
al
larger
sampl
survivor
heterogen
term
cancer
diagnos
andor
ctx
regimen
associ
found
use
regular
exercis
occurr
neuropath
pain
note
seven
profil
two
preclin
model
neuropath
pain
ie
spinal
cord
injuri
sci
shiao
leekubl
spinal
nerv
ligat
snl
chung
et
al
kim
chung
share
similar
whole
transcriptom
profil
dge
cohort
import
note
survivor
dge
profil
deriv
use
blood
sampl
preclin
find
came
differ
speci
ie
rodent
differ
tissu
ie
spinal
cord
drg
gene
express
differ
across
tissu
mainli
driven
small
number
gene
mele
et
al
suggest
gene
express
chang
one
tissu
may
provid
insight
gene
express
pattern
anoth
tissu
chang
gene
express
whole
blood
use
marker
neuron
injuri
tang
et
al
addit
gene
express
pattern
blood
hippocampu
prefront
cortex
show
broad
level
coexpress
witt
et
al
given
recent
interest
evalu
concord
discord
express
gene
repres
known
biomark
therapi
across
tissu
kosti
et
al
controversi
whether
chang
ge
peripher
blood
reflect
chang
within
pn
cn
colleoni
sacerdot
seok
et
al
jaggi
et
al
find
similar
human
whole
blood
preclin
model
neuropath
pain
neuron
tissu
ie
rat
drg
mous
sc
futur
research
evalu
gene
similar
uniqu
tissu
type
relat
pipn
anoth
point
worth
note
preclin
studi
identifi
use
epa
differ
ge
evalu
day
month
nerv
injuri
evalu
time
frame
consist
chronic
pain
phenotyp
perhap
relev
cohort
survivor
pipn
year
epa
analysi
evalu
specif
preclin
human
studi
cipn
pipn
taken
togeth
find
suggest
addit
perturb
pathway
associ
mitochondri
dysfunct
kober
et
al
c
miaskowski
et
al
journal
neuroimmunolog
perturb
proand
antiinflammatori
pathway
associ
neuroinflamm
found
cancer
survivor
pipn
furthermor
whole
transcriptom
profil
dge
pattern
preclin
clinic
studi
provid
addit
support
find
sever
limit
need
consid
sampl
size
rel
small
extrem
well
character
sampl
breast
cancer
survivor
without
pipn
note
differ
found
total
cumul
dose
paclitaxel
survivor
receiv
although
significantli
differ
group
studi
exercis
regular
may
contribut
differ
differenti
gene
express
breast
cancer
survivor
without
pipn
given
evalu
differ
gene
express
drg
neuron
done
live
individu
like
other
langjahr
et
al
uceyl
et
al
evalu
differ
rna
express
use
peripher
blood
limit
use
whole
blood
evalu
pattern
express
tissu
includ
blood
show
largest
number
uniqu
express
gene
mele
et
al
blood
smallest
number
express
transcript
across
tissu
consortium
baselin
blood
share
similar
wholetranscriptom
pattern
drg
well
cn
pn
tissu
ray
et
al
studi
first
provid
molecular
evid
neuroinflammatori
mechan
identifi
preclin
model
variou
type
neuropath
pain
includ
cipn
makker
duffi
wang
et
al
found
peripher
blood
leukocyt
cancer
survivor
persist
pipn
despit
limit
analys
rna
blood
observ
profil
dge
perturb
process
suggest
persist
damag
andor
chang
pn
given
survivor
pipn
approxim
four
year
find
suggest
chronic
neuroinflamm
involv
mainten
neuropath
pain
condit
futur
studi
need
evalu
differ
epigenet
chang
ie
methyl
microrna
survivor
without
pipn
may
reflect
chang
regul
pattern
supplementari
data
articl
found
onlin
http
author
declar
potenti
conflict
interest
respect
research
authorship
andor
public
articl
